The FDA’s recent move to grant emergency use authorization for convalescent plasma as a potential treatment for severe COVID-19 was met with controversy. With many critics pointing out a lack of available data to support the treatment. CoronavirusCOVID-19COVID19COVID19 immune systemdonorimmune systemIMMUNITYNandiplasmaSeveresmallStudySupportstherapyvideoVITAMINvlogYouTubeRelated Posts COVID’s New Variant Is Spreading Faster Than Expected April 18, 2026 COVID’s New Variant Is Spreading Faster Than Expected April 16, 2026 These Aren’t Just Hormone Problems April 16, 2026 New COVID Variant ‘Cicada’ Spreading Across U.S. | Seniors at Highest Risk April 15, 2026 Persistent immune activation and MS explosion #diseaseprevention April 13, 2026 Cicada COVID Variant Spreading in U.S. | What Doctors Want You to Know Now April 12, 2026